The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa

International Ophthalmology

Volumn 27, Issue 2-3, 2007, Pages 125-130

  Khairallah, Moncef ^a   Zaouali, Sonia ^a   Messaoud, Riadh ^a   Chaabane, Sami ^a   Attia, Sonia ^a   Ben Yahia, Salim ^a   Hmidi, Kamel ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

North Africa; Tunisia; Vogt Koyanagi Harada disease

Indexed keywords

CORTICOSTEROID; CYCLOPLEGIC AGENT; CYCLOSPORIN; METHYLPREDNISOLONE; STEROID;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FOLLOW UP; GLAUCOMA; HIGH RISK POPULATION; HUMAN; INTRAOCULAR HYPOTENSION; MALE; MEDICAL RECORD REVIEW; OCULAR FIBROSIS; ONSET AGE; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; RECURRENT DISEASE; SEX DIFFERENCE; SUBRETINAL NEOVASCULARIZATION; TOXOPLASMOSIS; TREATMENT DURATION; TUNISIA; UNSPECIFIED SIDE EFFECT; UVEITIS; VISUAL ACUITY; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; TUNISIA; UVEOMENINGOENCEPHALITIC SYNDROME; VISUAL ACUITY;

EID: 34250363603     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-006-9013-x     Document Type: Article

References (22)

1. Moorthy RS, Inomata H, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39:265-292
2. Khairallah M, Yahia SB, Ladjimi A, Messaoud R et al (2006) Pattern of uveitis in a referral center in Tunisia, North Africa. Eye 2006:1-7
3. Read RW, Holland GN, Rao NA et al (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol 131:647-652
4. Mondkar SV, Biswas J, Ganesh SK (2000) Analysis of 87 cases with Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 44:296-301
5. Rajendram R, Evans M, Rao NA (2005) Vogt-Koyanagi-Harada Disease. Int Ophthalmol Clin 45:115-134
6. Read RW, Rao NA, Cunningham ET (2000) Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 11:437-442
7. Belfort Junior R, Nishi M, Hayashi S et al (1988) Vogt-Koyanagi-Harada's disease in Brazil. Jpn J Ophthalmol 32:344-347
8. Bykhovskaya I, Thorne JE, Kempen JH et al (2005) Vogt-Koyanagi-Harada disease: Clinical outcomes. Am J Ophthalmol 140:674-678
9. Tabbara KF, Chavis PS, Freeman WR (1998) Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 76:723-726
10. Rathinam SR, Vijayalakshmi P, Namperumalsamy P et al (1998) Vogt-Koyanagi-Harada syndrome in children. Ocul Immunol Inflamm 6:155-161
11. Touitou V, Escande C, Bodaghi B et al (2005) Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome. J Fr Ophtalmol 28:9-16
12. Beniz J, Forster DJ, Lean JS et al (1991) Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 11:275-280
13. Ohno SMR, Matsuda H (1988) Clinical studies on Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 32:334-343
14. Bouchenaki NHC (2001) The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada Disease. Ophthalmology 108:54-64
15. Nakamura S, Nakazawa M, Yoshioka M et al (1996) Melanin-laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol 114:1184-1188
16. Rubsamen PE, Gass JD (1991) Vogt-Koyanagi-Harada Syndrome: Clinical course, therapy and long-term visual outcome. Arch Ophthalmol 109:682-687
17. Paredes I, Ahmed M, Foster CS (2006) Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 14:87-90
18. Yamaki K, Hara K, Sakuragi S (2005) Application of revised diagnostic criteria for Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 49:143-148
19. Sugiura S (1978) Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 22:9-35
20. Fujioka TFM, Okinami S (1980) A statistic study of Vogt-Koyanagi-Harada syndrome. Acta Soc Ophtalmol Jpn 84:1979-1982
21. Rao NA (1997) Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye 11:213-216
22. Read RW, Rechedouni A, Butani N et al (2001) Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131:599-606